Skip to main content
Clinical Trials/NCT01570062
NCT01570062CompletedPhase 2

Subclinical Cardiovascular Health Benefits of Interventions to Reduce Exposure to Combustion-Derived Particulate Air Pollution

Simon Fraser University2 sites in 1 country83 target enrollmentStarted: November 2011Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Completed
Enrollment
83
Locations
2
Primary Endpoint
Difference in reactive hyperemia measurement after HEPA filtration

Study Overview

Brief Summary

This study is focused on the effects of HEPA filtration to reduce exposures to combustion-derived air pollution (CDAP). Specifically, the study will evaluate the health benefits of HEPA filters and compare the cardiovascular toxicity of two major sources of CDAP, specifically traffic and residential wood combustion.

Specifically, the purpose of this study is to evaluate the ability of portable high efficiency particle air (HEPA) filters to reduce exposures to PM2.5 and air pollution indoors and to improve subclinical indicators of microvascular function and systemic inflammation among healthy adult participants.

The investigators hypothesize that HEPA filter use will help decrease indoor concentrations of CDAP thereby helping to mitigate the associated cardiovascular risks.

Detailed Description

To address knowledge gaps about health risks of specific pollution sources and to provide new evidence on the health benefits of air pollution interventions, the objectives of this study are: 1) quantify the relationship between low-level exposures to combustion-derived PM air pollution and subclinical indicators of cardiovascular disease risk; and 2) compare the relative impact of HEPA filtration for two major PM sources (traffic and residential wood combustion) on these indicators.

The use of HEPA filters may help to mitigate cardiovascular risks factors caused by combustion-derived air pollution (CDAP), (specifically woodstove and traffic emissions). We hypothesize that HEPA filter use and improved woodstove technology will help decrease indoor occurrences of CDAP. This project will help address knowledge gaps in CDAP-related health risks and benefits of interventions. Specific objectives include establishing a relationship between exposure to CDAP and biomarkers of cardiovascular risk and evaluating the impact of HEPA filter use towards improved indoor air quality and health indicators.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
19 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • 19 years or older
  • non-smoking household
  • lives within study boundaries and in areas of interest

Exclusion Criteria

  • heart disease
  • hypertension
  • arthritis
  • gum disease
  • occupationally exposed to traffic exposures &/or woodsmoke
  • if female, pregnant

Outcomes

Primary Outcomes

Difference in reactive hyperemia measurement after HEPA filtration

Time Frame: after 1 week of filtration

Participants endothelial function are tested after 1 week of HEPA filtration and after 1 week of non-HEPA filtration (placebo filtration).

Secondary Outcomes

  • Difference in C-Reactive Protein after HEPA Filtration(after 1 week of filtration)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ryan Allen

Assistant Professor

Simon Fraser University

Study Sites (2)

Loading locations...

Similar Trials